Joha Park
Senior Computational Scientist at Intellia Therapeutics
E-mail:
[firstname][lastname] AT gmail.com
I’m a computational biologist specializing in sequencing and in imaging data analysis. I build and develop computational solutions to streamline early clinical research and development. At Intellia, I’m focusing on the off-target discovery and validation for CRISPR-Cas gene editing systems for cell and gene therapy.
Before Intellia, I was a postdoc in the Chung lab. I had worked on hydrogel-based tissue engineering (review) and microscopy imaging data analysis. I developed eMAP which enables superresolution imaging on a cleared and expanded tissue-gel that maintains exceptional antigenicity. Typical datasets I analyzed were large-scale confocal/light-sheet microscopy images of those tissue-gel hybrids, which require dedicated machine learning techniques and efficient parallelization of computation.
Prior to that, I did my PhD in the Narry Kim lab to study RNA biology. I carried out diverse next-generation sequencing (NGS) data analysis to study various noncoding RNAs and mRNA poly(A) tails. Besides the standard NGS technologies such as bulk or single-cell RNA-seq, I have extensive experience in designing and analyzing custom sequencing libraries such as fCLIP-seq, TAIL-seq, and mTAIL-seq.
As a scientist, my long-term research interest lies in single-cell and computational genomics in the therapeutics context.
recent news
Apr 3, 2023 | I have joined the Computational Sciences team at Intellia Therapeutics! |
---|---|
Feb 27, 2023 | LARP1-poly(A) study is published online (finally!) (link) |
May 24, 2022 | LARP1-poly(A) study is accepted for publication in Nature Structural & Molecular Biology ! |
Apr 1, 2022 | Appointed as a Picower Postdoctoral Fellow |
Jan 13, 2022 | eMAP is covered in a news article from Picower (link) |